
H2-Gamendazole
CAS No. 877768-84-8
H2-Gamendazole( —— )
Catalog No. M36435 CAS No. 877768-84-8
H2-Gamendazole is a novel compound for spermatogenesis inhibition and cancer therapy as an inhibitor of heat shock proteins and/or elongation factor 1 alpha, and is an Hsp90 regulator.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 181 | Get Quote |
![]() ![]() |
5MG | 316 | Get Quote |
![]() ![]() |
10MG | 473 | Get Quote |
![]() ![]() |
25MG | 814 | Get Quote |
![]() ![]() |
50MG | 1095 | Get Quote |
![]() ![]() |
100MG | 1467 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameH2-Gamendazole
-
NoteResearch use only, not for human use.
-
Brief DescriptionH2-Gamendazole is a novel compound for spermatogenesis inhibition and cancer therapy as an inhibitor of heat shock proteins and/or elongation factor 1 alpha, and is an Hsp90 regulator.
-
DescriptionH2-Gamendazole is a derivative of Lonidamine that reduces cyst formation in polycystic kidney disease and is used in autosomal dominant polycystic kidney disease research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetHSP
-
RecptorHSP
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number877768-84-8
-
Formula Weight417.21
-
Molecular FormulaC18H13Cl2F3N2O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (299.61 mM; Ultrasonic (<60°C)
-
SMILESC(N1C=2C(C(CCC(O)=O)=N1)=CC=C(C(F)(F)F)C2)C3=C(Cl)C=C(Cl)C=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Shirin V Sundar, et al. The lonidamine derivative H2-gamendazole reduces cyst formation in polycystic kidney disease. Am J Physiol Renal Physiol. 2022 Oct 1;323(4):F492-F506.??
molnova catalog



related products
-
KU675
A novel, second-generation C-terminal Hsp90 inhibitor with Kd of 191 and 726 uM for Hsp90α and Hsp90β, respectively.
-
Geldanamycin
Geldanamycin is a natural existing HSP90 inhibitor with Kd of 1.2 μM, specifically disrupts glucocorticoid receptor (GR)/HSP association.
-
MAL3-101
MAL3-101 is a Hsc70 modulator that inhibits Hsp70 ATPase activity, exhibits antiproliferative activity in breast cancer cells SK-BR-3 with IC50 of 27 uM.